Tirze-Pep 5mg by Dragon Pharma

Dragon Pharma
Key Facts
ProductTirze-Pep 5mgManufacturerDragon PharmaActive substanceTirzepatide (GIP/GLP-1 dual agonist)Concentration5 mg per vialFormLyophilized peptide for injectionClassMetabolic research peptideBest forAppetite control, entry trials
Available Domestic
$90.00
$90.00
In Stock
Manufacturer Dragon Pharma
Brand Tirzepatide
Substance Tirzepatide
Concentration 5 mg
Pack Size vial
Shipping

What Is Tirze-Pep 5mg?

Tirze-Pep by Dragon Pharma is the 5 mg format of its tirzepatide research peptide. Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it engages two gut-hormone pathways at once instead of the single pathway used by classic GLP-1 peptides. The 5 mg vial is the natural entry point for a first metabolic trial.

The most common use is appetite regulation during fat loss research. A single 5 mg vial delivers either two weeks at the 2.5 mg weekly starting reference or one full 5 mg maintenance dose, so it is the smallest practical way to test tolerance before committing to a longer protocol.

Like all Dragon Pharma peptides it arrives lyophilized and is reconstituted with bacteriostatic water before subcutaneous injection. Tirze-Pep 5mg is a laboratory research peptide sold for research purposes.

Tirze-Pep 5mg Research Use

The 5 mg vial is easiest to measure when reconstituted with 1 ml of bacteriostatic water, giving a clean 5 mg per ml solution: the 2.5 mg weekly starting dose is then exactly 0.5 ml. A 2 ml dilution would give 2.5 mg per ml for even larger, easier volumes.

Handling step Detail
Vial content 5 mg tirzepatide, lyophilized powder
Diluent 1 ml bacteriostatic water
Final concentration 5 mg per ml (with 1 ml)
Route Subcutaneous injection, once weekly
Storage Refrigerate after reconstitution

Reconstitution

Below are the commonly referenced doses for a tirzepatide research trial, with volumes for a 5 mg per ml reconstitution.

Study period Weekly dose Injection volume
Weeks 1-4 (start) 2.5 mg 0.5 ml
Weeks 5-8 5 mg 1.0 ml
Tolerance check single 5 mg dose 1.0 ml

A 5 mg vial gives two injections at the 2.5 mg reference or one single 5 mg dose. For a full multi-week titration study you need several vials, which is where the larger 10 mg format becomes more economical.

Tirze-Pep 5mg Stacks

Tirze-Pep is a metabolic and appetite-control product, so stacks usually combine it with energy, lean-mass or recovery compounds. Every partner below is from the same Dragon Pharma line.

Stack Research goal
Tirze-Pep 5mg + SLU-PP-332 Work capacity and metabolic demand in a deficit
Tirze-Pep 5mg + Tesamorelin Appetite control with recovery rhythm support
Tirze-Pep 5mg + SS-31 50mg Steady daily energy during calorie restriction
Tirze-Pep 5mg + Anavar 10 Lean tissue retention in cutting research
Tirze-Pep 5mg + Ipamorelin Recovery and sleep support while dieting hard
Tirze-Pep 5mg + AOD 9604 5 mg Fat metabolism angle in an early trial

Tirze-Pep 5mg Side Effects and Precautions

The 5 mg format is the lower-total option, so it is the right choice for checking individual tolerance first. The effects below are the ones most often reported with tirzepatide research use.

  • Nausea: the leading side effect, most noticeable after the first injection and after any dose increase.
  • Slower digestion: food sits longer in the stomach, which is part of the mechanism but can feel heavy.
  • Appetite loss: expected and desired for the protocol, but intake should be monitored in lean subjects.
  • Digestive disturbance: occasional vomiting, diarrhea or constipation, usually transient.
  • Injection site redness: mild and local.
Note: do not double up weekly doses if a shot is missed, and do not jump straight to a high maintenance dose. Start low, hold for four weeks, and only then consider titration.

For research purposes only. Tirze-Pep 5mg by Dragon Pharma is a laboratory research peptide, not a medicine and not approved for human consumption. Store responsibly and follow your local laws.

What is Tirze-Pep 5mg?

Tirze-Pep is Dragon Pharma's tirzepatide research peptide, supplied as a 5 mg lyophilized vial. Tirzepatide is a dual GIP and GLP-1 receptor agonist used in metabolic research.

What is the difference between Tirze-Pep 5mg and 10mg?

The active substance is identical - only the total amount per vial differs. The 5 mg vial suits short trials and the starting dose, while the 10 mg vial covers a longer titration study more economically.

How long does a 5 mg vial of Tirze-Pep last?

At the 2.5 mg once-weekly starting reference, a 5 mg vial gives two weekly doses. Used as a single 5 mg maintenance dose, it lasts one week.

How do I reconstitute the Tirze-Pep 5 mg vial?

Add 1 ml of bacteriostatic water to get a 5 mg per ml solution, which makes the 2.5 mg dose exactly 0.5 ml. Swirl gently and refrigerate after mixing.

What dose do research protocols use?

Most protocols start at 2.5 mg once a week for four weeks before any increase. From there the reference can move to 5 mg weekly, which uses the whole 5 mg vial in one dose.

How does tirzepatide work for weight loss?

Tirzepatide activates both GIP and GLP-1 receptors, which reduces appetite, slows gastric emptying and improves how the body handles food intake. The result is an easier, steadier calorie deficit.

How does tirzepatide compare to semaglutide?

Semaglutide works on the GLP-1 receptor only, while tirzepatide adds GIP receptor activation. In head-to-head research, the dual pathway produced greater average weight loss.

What are the main side effects?

Nausea and other gastrointestinal effects are the most common, especially at the start and after dose increases. They are usually managed by slow titration, small meals and good hydration.

How fast do results appear with tirzepatide?

Appetite suppression is often felt within days of the first dose. Body composition changes accumulate over weeks to months, which is why multi-vial protocols are the norm.

Is Tirze-Pep by Dragon Pharma legit?

Tirze-Pep is a branded tirzepatide research peptide from the Dragon Pharma line sold through gasproids.com. It ships as a lyophilized research product and is not intended for human consumption.